Health Condition 1: O30-O48- Maternal care related to the fetus and amniotic cavity and possible delivery problems
Conditions
Interventions
Intervention1: Camylofin dihydrochloride: interventional drug is antispasmodic drug
single dose of 1 ml drug will be injected im at 5cm of dilatation till delivery
Control Intervention1: nil: nil
Sponsors
Nil
Eligibility
Inclusion criteria
Inclusion criteria: primigravidas in age group of 18-35 years with gestational age of 37-40 weeks with singleton foetus in vertex presentation, in active phase of labour. (Active phase of labour- 5cm or more cervical dilatation with uterine contractions.
Exclusion criteria
Exclusion criteria: any antenatal pregnancy complications like preeclampsia, eclampsia , suspected cephalopelvic disproportion, premature rupture of membranes, placenta previa, abruptio placenta, abnormal presentation, preterm labour, multiple pregnancy and patients requiring induction or use of any oxytocic drugs and any other medical disorders like diabetes, cardiac, renal and hepatic disorders. Known hypersensitivity to drugs will be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to hasten the process of labour and to see the effect on cervical dilatattion rateTimepoint: from intervention to delivery | — |
Secondary
| Measure | Time frame |
|---|---|
| nausea, vomitting, dryness of mouth and tachycardiaTimepoint: from intervention to 24 hours after dlivery | — |
Countries
India
Contacts
Public ContactThacker Shriya Himmat
Krishna institute of medical sciences karad
Outcome results
None listed